Edition:
India

Abeona Therapeutics Inc (ABEO.OQ)

ABEO.OQ on NASDAQ Stock Exchange Capital Market

13.25USD
17 Aug 2018
Change (% chg)

$-0.45 (-3.28%)
Prev Close
$13.70
Open
$13.85
Day's High
$14.25
Day's Low
$13.00
Volume
155,641
Avg. Vol
202,705
52-wk High
$22.70
52-wk Low
$7.50

Latest Key Developments (Source: Significant Developments)

Abeona Therapeutics May Offer And Sell Common Shares Of Up To $150 Mln Through Jefferies
Saturday, 18 Aug 2018 

Aug 17 (Reuters) - Abeona Therapeutics Inc ::ABEONA THERAPEUTICS - MAY OFFER AND SELL COMMON SHARES OF UP TO $150 MILLION THROUGH JEFFERIES LLC.  Full Article

Abeona Therapeutics Q2 Loss Per Share $0.25
Friday, 10 Aug 2018 

Abeona Therapeutics Inc ::ABEONA THERAPEUTICS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS.Q2 LOSS PER SHARE $0.25.Q2 REVENUE $819,000 VERSUS $217,000.Q2 REVENUE VIEW $1.1 MILLION -- THOMSON REUTERS I/B/E/S.Q2 EARNINGS PER SHARE VIEW $-0.19 -- THOMSON REUTERS I/B/E/S.CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF JUNE 30, 2018 WERE $120 MILLION.  Full Article

Abeona Therapeutics Q2 Loss Per Share $0.25
Friday, 10 Aug 2018 

Abeona Therapeutics Inc ::ABEONA THERAPEUTICS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS.Q2 LOSS PER SHARE $0.25.Q2 REVENUE $819,000 VERSUS $217,000.Q2 REVENUE VIEW $1.1 MILLION -- THOMSON REUTERS I/B/E/S.Q2 EARNINGS PER SHARE VIEW $-0.19 -- THOMSON REUTERS I/B/E/S.  Full Article

Abeona Therapeutics Provides Clinical Update On MPS IIIA Gene Therapy Trial
Friday, 18 May 2018 

May 18 (Reuters) - Abeona Therapeutics Inc ::ABEONA THERAPEUTICS PROVIDES CLINICAL UPDATE ON MPS IIIA GENE THERAPY TRIAL AT THE 21ST ANNUAL ASGCT MEETING.ABEONA THERAPEUTICS- ABO-102 18-MONTH EFFICACY & SAFETY DATA CONTINUE TO DEMONSTRATE TIME- & DOSE-DEPENDENT REDUCTIONS IN UNDERLYING DISEASE PATHOLOGY.ABEONA THERAPEUTICS- RESULTS FROM PHASE 1/2 CLINICAL TRIAL FOR ABO-102 SHOW DURABLE BIOPHYSICAL REDUCTIONS OF DISEASE BURDEN.ABEONA THERAPEUTICS INC - ABO-102 IS WELL-TOLERATED IN ALL SUBJECTS TO DATE, WITH NO DRUG-RELATED SERIOUS ADVERSE EVENTS REPORTED.  Full Article

Abeona Therapeutics Posts Q1 Loss Of $0.18 Per Share
Friday, 11 May 2018 

May 11 (Reuters) - Abeona Therapeutics Inc ::ABEONA THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS.Q1 LOSS PER SHARE $0.18.Q1 REVENUE $2.6 MILLION VERSUS $186,000.Q1 REVENUE VIEW $228,000 -- THOMSON REUTERS I/B/E/S.Q1 EARNINGS PER SHARE VIEW $-0.19 -- THOMSON REUTERS I/B/E/S.CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2018 WERE $132 MILLION, COMPARED TO $137.8 MILLION AS OF DECEMBER 31, 2017.  Full Article

Abeona Announces FDA Grants Rmat Designation To ABO-102 Gene Therapy In MPS Iiia
Monday, 23 Apr 2018 

April 23 (Reuters) - Abeona Therapeutics Inc ::ABEONA ANNOUNCES FDA GRANTS RMAT DESIGNATION TO ABO-102 GENE THERAPY IN MPS IIIA.ABEONA THERAPEUTICS INC - COMPANY CONTINUES TO ENGAGE FDA ON ITS ONGOING PHASE 1/2 TRIAL.ABEONA - FDA GRANTED REGENERATIVE MEDICINE ADVANCED THERAPY DESIGNATION TO ABO-102, CO'S GENE THERAPY FOR TREATMENT OF SANFILIPPO SYNDROME TYPE A.  Full Article

Abeona Q3 loss per share $0.13
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Abeona Therapeutics Inc :Abeona reports third quarter 2017 financial results and recent business highlights.Q3 loss per share $0.13.Q3 revenue $219,000 versus I/B/E/S view $220,000.Q3 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S.  Full Article

Abeona Therapeutics prices offering of five million shares at $16 per share
Tuesday, 17 Oct 2017 

Oct 16 (Reuters) - Abeona Therapeutics Inc :Announces pricing of public offering of common stock.Pricing underwritten public offering of five million shares of common stock at a public offering price of $16.00 per share​.  Full Article

Abeona Therapeutics announces public offering of common stock
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Abeona Therapeutics Inc :Abeona Therapeutics announces public offering of common stock.  Full Article

Abeona Therapeutics to receive $13.85 mln of grants for development of Sanfilippo gene therapy programs​
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Abeona Therapeutics Inc :Abeona Therapeutics Inc - ‍nine global foundations collaborate to grant $13.85 million for continued advancement of lead Sanfilippo gene therapy programs​.  Full Article